US Stock MarketDetailed Quotes
HAO Haoxi Health Technology
- 0.208
- -0.001-0.24%
Close Nov 1 16:00 ET
- 0.194
- -0.014-6.78%
Post 20:02 ET
10.45MMarket Cap5.20P/E (TTM)
0.218High0.192Low3.39MVolume0.209Open0.209Pre Close688.19KTurnover16.33%Turnover Ratio5.20P/E (Static)50.23MShares10.60052wk High0.93P/B4.32MFloat Cap0.14552wk Low--Dividend TTM20.75MShs Float10.600Historical High--Div YieldTTM12.47%Amplitude0.145Historical Low0.203Avg Price1Lot Size
Haoxi Health Technology Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | |
|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||
| Cash flow from continuing operating activities | 14.28%-747.58K | -29.14%-872.13K | -127.36%-675.36K | 2.47M |
| Net income from continuing operations | 33.20%1.29M | 296.49%969.75K | -19.56%244.59K | --304.07K |
| Operating gains losses | ---- | ---- | ---- | --10.12K |
| Depreciation and amortization | 25.90%10.57K | 279.43%8.39K | 438.20%2.21K | --411 |
| Other non cash items | ---- | ---- | ---- | --180.62K |
| Change In working capital | -10.78%-2.05M | -100.65%-1.85M | -142.82%-922.16K | --2.15M |
| -Change in receivables | -4,992.31%-217.9K | -100.64%-4.28K | 325.43%665.62K | ---295.26K |
| -Change in prepaid assets | -19.73%-2.9M | -641.06%-2.42M | 178.33%447.51K | ---571.32K |
| -Change in payables and accrued expense | 266.06%1.4M | 49.65%-840.24K | -159.68%-1.67M | --2.8M |
| -Change in other current assets | -1,086.36%-90.38K | -108.43%-7.62K | 179.46%90.41K | ---113.79K |
| -Change in other current liabilities | 207.38%90.38K | 133.53%29.4K | 5.00%-87.69K | ---92.3K |
| -Change in other working capital | -123.54%-328.08K | 477.49%1.39M | -185.84%-369.22K | --430.14K |
| Cash from discontinued investing activities | ||||
| Operating cash flow | 14.28%-747.58K | -29.14%-872.13K | -125.50%-675.36K | --2.65M |
| Investing cash flow | ||||
| Cash flow from continuing investing activities | -6,777.04%-3.13M | -423.11%-45.5K | -166.65%-8.7K | -3.26K |
| Net PPE purchase and sale | -21.69%-55.37K | -423.11%-45.5K | -166.65%-8.7K | ---3.26K |
| Net other investing changes | ---3.07M | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||
| Investing cash flow | -6,777.04%-3.13M | -423.11%-45.5K | -166.65%-8.7K | ---3.26K |
| Financing cash flow | ||||
| Cash flow from continuing financing activities | 417.24%9.32M | 93.16%1.8M | 135.72%933.22K | -2.61M |
| Net issuance payments of debt | -1.19%362.47K | 32.04%366.83K | 120.68%277.81K | ---1.34M |
| Net common stock issuance | 350.06%8.98M | 1,116.60%1.99M | --163.92K | ---- |
| Net other financing activities | 97.43%-14.33K | -213.64%-558.52K | 138.72%491.49K | ---1.27M |
| Cash from discontinued financing activities | ||||
| Financing cash flow | 417.24%9.32M | 93.16%1.8M | 135.72%933.22K | ---2.61M |
| Net cash flow | ||||
| Beginning cash position | 309.93%1.2M | 425.20%293.51K | 174.89%55.89K | --20.33K |
| Current changes in cash | 515.52%5.45M | 255.17%884.94K | 660.44%249.16K | --32.77K |
| Effect of exchange rate changes | -77.38%5.6K | 314.63%24.76K | -513.26%-11.53K | --2.79K |
| End cash Position | 453.17%6.66M | 309.93%1.2M | 425.20%293.51K | --55.89K |
| Free cash flow | 12.50%-802.94K | -34.15%-917.63K | -125.86%-684.06K | --2.65M |
| Currency Unit | USD | USD | USD | USD |
| Audit Opinions | Unqualified Opinion | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data